PoZibio Honored with the 2025 Natural Choice Award: Ingredients Edition
PoZibio®, the patented postbiotic composition of Lactobacillus paracasei developed by Postbiotics Inc., has been honored with the 2025 Natural Choice Award: Ingredients Edition for its breakthrough contribution to gut and healthy-aging innovation. Recognized for its clinically supported ability to strengthen the gut barrier, reduce age-related inflammation, and promote cognitive and metabolic wellness through the gut–brain axis, PoZibio® sets a new standard for stable, science-driven postbiotics that meet the growing demand for next-generation functional ingredients.
Read More
Dr. Hariom Yadav's Participation in the Probiota Americas Conference
Dr. Hariom Yadav, a leading researcher in microbiome and aging science and Director of the USF Center for Microbiome Research, played a significant role in the NutraIngredients-USA article titled "The microbiome’s next target: Healthspan," published on June 20, 2025. During the Probiota Americas conference in Vancouver, Dr. Yadav participated in a panel discussion on navigating weight management for microbiome modulators. His expertise highlighted the microbiome's role as a "metabolic detoxifier," emphasizing its influence on metabolism, weight, and long-term health beyond digestion. He positioned probiotics as targeted tools that trigger a cascade of signals to enhance mucin production, strengthen the gut barrier, combat metabolic dysfunction, and promote healthy aging phenotypes. Dr. Yadav underscored the importance of understanding what microbes consume, noting its potential to improve health outcomes. His insights reinforced the article’s focus on the microbiome’s critical role in enhancing healthspan and addressing the biological wear of modern lifestyles.
Read More
Physicians, anthropologists and marine biologists start at the soil in launch of program to address nature’s impact on human health
Can what you eat influence the health of your brain now and in the future? That is a key question that USF Health Morsani College of Medicine researchers hope to answer with the help of a noninvasive Microbiome in the Aging Gut and Brain (MiaGB) study. The new clinical study expects to enroll 400 adults ages 60 and older in the Tampa Bay region and beyond — both those who are cognitively healthy as well as those diagnosed with mild cognitive impairment and early-stage dementia.
Read More
